COVID-19

Read more about Gujarat based lab provides whole genome sequence, helpful in drug targets and vaccine development

Read more about Loss of Smell and Taste Validated as COVID-19 Symptoms in Patients with High Recovery Rate : Study

Loss of smell and taste has been anecdotally linked to COVID-19 infections. In a study published April 12, 2020 in the journal International Forum of Allergy & Rhinology , researchers at UC San Diego Health report the first empirical findings that strongly associate sensory loss with COVID-19, the respiratory disease caused by the novel coronavirus.

14 April 2020

Recruitment for Pharmacists (09 posts) at Southern Railway - Government Jobs

Read more about ICMR approves DBT institute as new COVID-19 testing facility

The bioassay laboratory of Department of Biotechnology’s Faridabad-based Translational Health Science and Technology Institute (THSTI) will now function as an extension of diagnostic facility of ESIC Medical College and Hospital, Faridabad for COVID-19 testing. It will be the first and only COVID-19 testing facility in the Faridabad region.

13 April 2020

Special Call for COVID-19 Ignition Grants by The Indo-U.S. Science and Technology Forum

Across the world, countries are being challenged by the COVID-19 pandemic in ways they have never been before. Science, Engineering, and Technology will play a critical role in finding solutions to this global challenge through the development of new vaccines, devices, diagnostic tools, and information systems, as well as strategies to help communities and nations manage and deploy resources to combat this pandemic. Global challenges call for global collaborations and partnerships, bringing together the best and brightest scientists, engineers, and entrepreneurs to work together to find solutions not only to address the current pandemic, but also for the challenges that lie ahead. Collaborations and networks not only help to leverage and share expertise across S&T communities, thereby creating synergy, but often lead to the generation of innovative and transformative solutions. Collaboration, both national and international, facilitates the development of a diverse, globally-engaged science, engineering, and technology-enabled workforce.

Read more about FDA Issues Second Emergency Use Authorization to Decontaminate N95 Respirators

The U.S. Food and Drug Administration issued the second emergency use authorization (EUA) to decontaminate compatible N95 or N95-equivalent respirators for reuse by health care workers in hospital settings. This EUA will support decontamination of approximately 750,000 N95 respirators per day in the U.S.

Read more about EMA establishes task force to take quick and coordinated regulatory action related to COVID-19 medicines

As part of its health threat plan activated to fight COVID-19, the Agency has finalised and published the composition and objectives of its COVID-19 EMA pandemic Task Force (COVID-ETF), which assists Member States and the European Commission in dealing with development, authorisation and safety monitoring of therapeutics and vaccines intended for treatment or prevention of COVID-19.

Read more about Guidance on regulatory requirements in the context of the COVID-19 pandemic

The European Commission, EMA and the European medicines regulatory network have developed a question-and-answer (Q&A) document to provide guidance to stakeholders on adaptations to the regulatory framework to address challenges arising from the COVID-19 pandemic, with a particular focus on crucial medicines for use in COVID-19 patients.

Read more about Update on EU actions to support availability of medicines during COVID-19 pandemic

The continued availability of medicines is one of the most important priorities for EU authorities that are adopting measures to mitigate possible disruptions to the supply of medicines caused by the ongoing COVID-19 pandemic. The EU Executive Steering Group on Shortages of Medicines Caused by Major Events met virtually on 8 April to discuss ongoing activities aimed at ensuring a coordinated response to the challenges posed by the COVID-19 pandemic.